Web Exclusives

Elsevier’s Maria de Kleijn-Lloyd looks at UK researchers’ contribution to the fight against melanoma

With EU parliament elections fast approaching, Nick Hoile, director of Government Affairs at Publicis Resolute, considers the potential impact of a more Eurosceptic climate on health.

As Mental Health Awareness Week 2019 begins (13/5/19), King’s College London Professor of Psychiatry Allan Young offers his thoughts on how a new European pharmacovigilance consortium could pave the way for new mental health drugs for UK patients.

Dr Simon Hendricks, clinical strategy lead at FDB (First Databank), is excited by the recent attention from Whitehall to improving NHS prescribing. He asks what progress is already being made, what needs to happen next, and where technology can play a role.

PharmaTimes talks to Jenna McDonnell, Program Manager, Project Delivery & Operational Leader for TrialConsent, at clinical research technology group CRF Bracket

The rise of digital therapeutics and the shift of the health market towards payment for outcomes could be seen as a significant double threat to pharma. However, cross-industry collaboration could turn these threats into opportunities, says S3 Connected Health’s Jim O’Donoghue.

Compliance training should focus on promoting trust and integrity, rather than on fear of the consequences of non-compliance. Louise Vamvoukaki offers an insight into how AstraZeneca is working to ensure that its globally dispersed workforce are all living and breathing the same values and ethics.

Solving the challenge of increasing minority participation in clinical trials requires a long-term commitment and investment from the research community.

To mark World Haemophilia Day, Laurence Woollard talks to PharmaTimes about engaging today’s generation of young people living with the condition to advocate for nothing less than a bleed-free life

Ex England cricketer Jeremy Snape says pharma leaders looking to inspire their teams during volatile times should see what lessons they can learn from other industries faced with similar challenges

Patent-mapping research suggests that innovation-led newcomers may already be on to something new

Alex Dale looks at where we are with AI and how it might help pharma sales